SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001615219-22-000083
Filing Date
2022-05-12
Accepted
2022-05-12 16:17:07
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A salarius-defa14aer.htm DEFA14A 19100
2 image.jpg GRAPHIC 145774
3 image1.jpg GRAPHIC 149015
4 image2.jpg GRAPHIC 149792
5 image3.jpg GRAPHIC 129872
6 image4.jpg GRAPHIC 99765
7 image5.jpg GRAPHIC 65182
  Complete submission text file 0001615219-22-000083.txt   1039396
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36812 | Film No.: 22918038
SIC: 2834 Pharmaceutical Preparations